Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage cervical carcinoma who have intermediate risk factors following radical hysterectomy, a phase 3 trial found. The current standard for women with early-stage disease and intermediate-risk factors is radiotherapy alone...
.png)
Market Touch Signal · Finland · international digital desk
+358 400 512311
info@market-touch.org
